The Journal of Nuclear Medicine Vol. 41 No. 12 1973-1979
© 2000 by Society of Nuclear Medicine
Diagnostic Accuracy of 99mTc-Sestamibi Breast Imaging: Multicenter Trial Results
Iraj Khalkhali,
Javier Villanueva-Meyer,
Steven L. Edell,
James L. Connolly,
Stuart J. Schnitt,
Janet K. Baum,
Mary J. Houlihan,
Rhonda M. Jenkins and
Stephen B. Haber
Department of Radiology, Harbor UCLA Medical Center, Torrance, California; Department of Radiology, The University of Texas Medical Branch at Galveston, Galveston, Texas; Women's Imaging Center of Delaware, Newark, Delaware; Departments of Pathology, Radiology, and Surgery, Beth Israel Deaconess Medical Center, Boston, Massachusetts; and DuPont Pharmaceuticals Company, Wilmington, Delaware, and North Billerica, Massachusetts

View larger version (43K):
[in this window]
[in a new window]
|
FIGURE 1. Diagnostic statistics for 99mTc-sestamibi breast imaging in patients with palpable abnormalities. PPV = positive predictive value; NPV = negative predictive value.
|
|

View larger version (43K):
[in this window]
[in a new window]
|
FIGURE 2. Diagnostic statistics for 99mTc-sestamibi breast imaging in patients with nonpalpable abnormalities. PPV = positive predictive value; NPV = negative predictive value.
|
|

View larger version (25K):
[in this window]
[in a new window]
|
FIGURE 3. Diagnostic statistics for 99mTc-sestamibi breast imaging and for mammography in patients with palpable abnormalities. PPV = positive predictive value; NPV = negative predictive value.
|
|
Copyright © 2000 by the Society of Nuclear Medicine.